OncoMed Pharmaceuticals Inc. buy melinda
Start price
14.04.17
/
50%
€3.48
Target price
22.08.17
€7.67
Performance (%)
10.88%
End price
22.08.17
€3.86
Summary
This prediction ended on 22.08.17 with a price of €3.86. The prediction had a final performance of 10.88%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| OncoMed Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -2,53 % | -5,19 % | 4,91 % | 52,00 % |
| iShares Nasdaq 100 | -0,03 % | 1,56 % | 21,79 % | 95,66 % |
| iShares Nikkei 225® | -4,20 % | -7,55 % | 31,13 % | 52,99 % |
| iShares S&P 500 | -0,80 % | 0,16 % | 15,78 % | 66,53 % |
Comments by melinda for this prediction
In the thread OncoMed Pharmaceuticals Inc. diskutieren
es sollte funktionieren
$ 4.84
0,12 (+ 2,54%) Tarextumab - PINNACLE Studie Lungenkrebs, kleinzelliger
OMED
Stopped prediction by melinda for OncoMed Pharmaceuticals Inc.
OncoMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€0.88
17.03.19
17.03.19
€1.13
25.04.19
25.04.19
-8.72%
25.04.19
25.04.19
OncoMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.71
24.10.18
24.10.18
€2.16
22.01.19
22.01.19
-58.25%
22.01.19
22.01.19
OncoMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.21
04.01.17
04.01.17
€9.02
27.02.17
27.02.17
25.78%
27.02.17
27.02.17
OncoMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€22.13
04.12.13
04.12.13
€19.00
04.06.14
04.06.14
0.00%
04.06.14
04.06.14